title: Surrogate End Points and Their Validation in Oncology Clinical Trials.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA fezhao@jimmy.harvard.edu.
authors.forename: Fengmin
authors.initials: F
authors.lastname: Zhao
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000592:standards; D006801:Humans; D009369:Neoplasms / Q000737:chemistry* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D014408:Biomarkers, Tumor